Clinical trial suggests an anti-inflammatory drug could relieve difficult-to-treat depression

The Limitations of the Monoamine Hypothesis For decades, the pharmacological treatment of major depressive disorder (MDD) has been dominated by the monoamine hypothesis. This theory posits that depression is primarily…

The Promising Anti-Aging Drug Combination Dasatinib-Quercetin Linked to Significant Brain Damage in Mice

A widely investigated drug combination, lauded for its potential to combat aging, has revealed a serious and concerning downside: significant brain damage in laboratory mice. Researchers at the University of…

NIH Researchers Uncover Crucial Intracellular Mechanisms Driving GLP-1 Weight Loss Drug Efficacy and Variability

Researchers at the National Institutes of Health (NIH) have made significant strides in understanding the intricate internal signaling processes within brain cells that govern the effectiveness of GLP-1 weight loss…

Weight loss drug Ozempic linked to lower depression and anxiety risk

A landmark study has unveiled a surprising and potentially transformative aspect of medications commonly prescribed for type 2 diabetes and obesity. Drugs like Ozempic and Wegovy, belonging to the class…

Philippines Senator Ronald Dela Rosa Seeks Sanctuary in Parliament Amidst ICC Arrest Warrant for Role in Duterte’s Infamous Drug War

Philippines Senator Ronald Dela Rosa has sought refuge within the hallowed halls of the country’s parliament, a dramatic move occurring on Monday as law enforcement agencies moved to execute an…

Weight-loss drug semaglutide reduces heavy alcohol drinking in new clinical trial

A landmark clinical trial has demonstrated that semaglutide, the active pharmaceutical ingredient in widely used weight-loss and diabetes medications such as Wegovy and Ozempic, may offer a significant new therapeutic…

Canadian Researchers Uncover Novel Strategy to Slow Glioblastoma Growth and Identify Potential Repurposed Drug

A groundbreaking study by a collaborative team of Canadian researchers has illuminated a novel therapeutic avenue for glioblastoma, the most aggressive and currently incurable form of brain cancer. The findings,…

Wake-Promoting Drug Shows Promise in Combating Fatigue for Early Morning Shift Workers

Far more people work very early morning shifts than overnight schedules, yet many struggle with severe fatigue linked to shift work disorder. This condition can interfere with concentration, job performance,…

Wake-Promoting Drug Shows Promise for Early Morning Shift Workers Battling Fatigue

A groundbreaking clinical trial has illuminated a potential new avenue for addressing the pervasive issue of shift work disorder, particularly among the often-overlooked population of early morning shift workers. Researchers…

Canadian Researchers Uncover Novel Strategy to Combat Glioblastoma by Disrupting Tumor Microenvironment with Existing HIV Drug

A groundbreaking study led by a collaborative team of Canadian researchers from McMaster University and The Hospital for Sick Children (SickKids) has unveiled a significant new avenue for potentially treating…